Respiratory Disease

Respiratory Disease

Thinking made Easy (Free subscription) | 02/09/2008

Variations Of Rare Lung Disease Examined

Medical News Today (Free subscription) | 28/08/2008

Lymphangioleiomyomatosis, or LAM, is a rare but serious lung disease that may cause severe respiratory symptoms in patients. The often-fatal disease has no cure.

• Research Examines Variations of Rare Lung Disease - Curing Death by Curing Aging
• Research examines variations of rare lung disease - Physorg
• See the 5 articles on the same subject

Influenza Antibody Spray Success: Opens New Approach To Respiratory Disease Control

Medical,Health News and Articles (Free subscription) | 27/08/2008

Anadis Limited (ASX: ANX), a research driven biopharmaceutical company focused on polyclonal antibodies to address human disease, announced important progress concerning its accelerated program to develop a nasal antibody spray to provide immediate post-exposure prophylaxis against a range of influenza viruses. Working with an animal influenza challenge model in the laboratory of Professor Loreena...

• Influenza Antibody Spray Success: Opens New Approach To Respiratory Disease Control - Medical News Today

Study Provides Interesting Clues Into Why Some Children Are More Likely To Develop Into Adult Snorers, Says British Lung Foundation

Medical News Today (Free subscription) | 25/08/2008

A study has found that a predisposition to adult snoring can be established very early in life. The research published in BioMed Central's open access journal Respiratory Research describes possible childhood risk factors, including exposure to animals, early! respiratory or ear infections and growing up in a large family.

Tsunami Workers Report Respiratory Disease

The Post Chronicle (Free subscription) | 23/08/2008

In Norway, about 30 percent of the more than 100 people who helped with the search and recovery effort have asthmalike symptoms, Aftenposten reported....

CMS Releases National Hospital Quality Measures, Mortality Rates On USA Today, Agency Web Sites

Medical News Today (Free subscription) | 21/08/2008

CMS on Wednesday for the first time released mortality rates for Medicare beneficiaries at individual hospitals on its Hospital Compare Web site,

Most Deaths In 1918 Influenza Pandemic Caused By Bacterial Pneumonia

Medical News Today (Free subscription) | 20/08/2008

The majority of deaths during the influenza pandemic of 1918-1919 were not caused by the influenza virus acting alone, report researchers from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. Instead, most victims succumbed to bacterial pneumonia following influenza virus infection.

• Bacterial pneumonia caused most deaths in 1918 influenza pandemic; Implications for future pandemic planning - Smart Economy
• Bacterial Pneumonia Caused Most Deaths In 1918 Influenza Pandemic - Science Daily
• See the 9 articles on the same subject

Silver Is The Key To Reducing Pneumonia Associated With Breathing Tubes

Medical News Today (Free subscription) | 20/08/2008

People have long prized silver as a precious metal. Now, silver-coated endotracheal tubes are giving critically ill patients another reason to value the lustrous metal. In a study published in the Aug. 20, 2008 issue of the Journal of the American Medical Association, researchers at Washington University School of Medicine in St. Louis and the NASCENT Investigation Group, report that the silver-coated...

• Silver Is Key To Reducing Pneumonia Associated With Breathing Tubes - Science Daily
• Silver Is the Key to Reducing Pneumonia Associated with Breathing Tubes - Newswise
• See the 5 articles on the same subject

Inverness Medical Innovations Features Innovative TB Diagnostic - Clearview(R) TB ELISA At AIDS 2008

Medical News Today (Free subscription) | 09/08/2008

Inverness Medical Innovations, Inc. (Amex: IMA), a leading provider of near-patient diagnostics, monitoring and health management solutions, is featuring its new TB diagnostic test, the Clearview TB ELISA, at the International AIDS conference (AIDS 2008). The test, which was introduced to developing world markets in July 2008, provides a much needed aid in the diagnosis of Mycobacterium tuberculosis...

• Inverness Medical Innovations Features Innovative TB Diagnostic - Clearview(R) TB ELISA at AIDS 2008 - Red Orbit
• Inverness Medical Innovations Features Innovative TB Diagnostic - Clearview(R) TB ELISA at AIDS 2008 - The Earth Times Online Newspaper
• See the 4 articles on the same subject

Scottish Study Adds Support For World-Wide Ban On Smoking In Public Places

Medical News Today (Free subscription) | 04/08/2008

NHS Health Scotland, the national health improvement agency, has found a 17 per cent fall in admissions for heart attacks just one year after the smoking ban1 came into force. Undertaken by the University of Glasgow, this study is one of the most robust of its kind, and was commissioned as part of a national evaluation of the impact of Scotland's smokefree legislation.

Cochrane Review Evaluates Herbal Medicine From Schwabe Pharmaceuticals For Acute Respiratory Tract Infections

Medical News Today (Free subscription) | 31/07/2008

A recent report by the internationally renowned, independent Cochrane Collaboration adds further weight to the growing international popularity of standardized Pelargonium sidoides extract EPs® 7630 (Umckaloabo®) in the treatment of acute respiratory tract infections such as acute bronchitis and the common cold.

Inspire Provides Update On Cystic Fibrosis Clinical Program - Optimization Of TIGER-2 Trial Design

Medical News Today (Free subscription) | 31/07/2008

Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) announced modifications to the clinical protocol for TIGER-2, the Company's ongoing second Phase 3 trial with denufosol tetrasodium for the treatment of cystic fibrosis (CF). "The availability of the extensive data set from the positive TIGER-1 trial provides an excellent opportunity to optimize the TIGER-2 trial design," stated Christy L. Shaffer, Ph.D.,...

Talecris Biotherapeutics Receives Orphan Drug Designation For Aerosolized Form Of Alpha1-Antitrypsin (AAT) From The European Commission

Medical News Today (Free subscription) | 27/07/2008

Talecris Biotherapeutics, Inc. announced today that the European Commission followed an opinion of the Committee for Orphan Medicinal Products (COMP) and has granted orphan drug designation to Talecris' alpha-1 proteinase inhibitor (human) for inhalation use in the treatment of congenital Alpha1-Antitrypsin Deficiency (also known as AAT Deficiency or Alpha-1). Currently, there are no approved aerosolized...

Early Exposure To Tobacco Smoke Causes Asthma And Allergy

Medical News Today (Free subscription) | 22/07/2008

Babies exposed to cigarette smoke before birth or during the first months afterwards run a greater risk of developing asthma and allergy. This according to a doctoral thesis from the Swedish medical university Karolinska Institutet. It is a well known fact that babies are harmed by tobacco smoke in numerous ways, but it has always been difficult to separate the effects of the mother smoking during...

More Evidence Of Long-Term Problems From Regular Salmeterol For Asthma

Medical News Today (Free subscription) | 17/07/2008

People with asthma who regularly use salmeterol are at a greater risk of non-fatal serious adverse events than those using placebos. This conclusion was arrived at by a team of Cochrane Researchers who drew together data from 26 trials involving 62,630 patients.